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 Most widely used illicit drug
 Can be smoked, eaten, or in some rare cases liquid 
form
 Varies widely in cost and potency, but in general, most 
cannabis available currently is far more potent than 
cannabis consumed in 1960-70’s (4-5% THC vs 15-20% 
THC)
 Modern strains also lower in CBD (neuroprotective)
 Infinite number of nicknames based on region and strain of 
plant being referred to. Most common generic terms include 
“weed” and “pot”
 Most strains are variations of Cannabis Indica, Cannabis 
Sativa, or some hybrid
 Indica ~ “body high” relaxing, sedating
 Sativa ~ “head high” psychedelic, mind altering
 THC = main psychotropically active ingredient, most 
concentrated in plant resin
Sativa
 Acapulco Gold
















 Joints – Cannabis cigarettes
 Blunts – Hollowed out cheap cigars filled with Cannabis and re-
wrapped
 Bowls – Cannabis packed into the bowl of a pipe
 Bong – Pipe with water filter element
 Vaporizer – Heats Cannabis so that THC evaporates and can be inhaled 
without burning plant material
 Dabs – Highly concentrated resin “wax” (80-90% THC vs Hashish at 40-
50%). Wax can be “dabbed” onto bud or smoked directly via a “rig”
 “Dime bag” = $10 worth
 “Dub” = $20 worth
 A gram














 Slowed motor response, delayed reflexes
 Increased Appetite
 Injected Sclera (blood shot eyes): may be independent of smoking. THC 
lower BP  vasodilation
 Amotivation
 Increased novelty (Golden Girls reruns)
 Time Dilation “chronic”
 “Paranoia” (usually refers to feelings of self consciousness as opposed to 
frank delusions) 
 Psychosis
 Conflicting Data from Research
 Clear Cognitive effects with intoxication including tracking, motor 
coordination, visual functions, and particularly complex tasks that 
require divided attention
 However, only modest impairments on actual road tests
 “Experienced smokers who drive on a set course show almost no 
functional impairment under the influence of marijuana, except when 
it is combined with alcohol” (Sewell, et al. THE EFFECT OF CANNABIS COMPARED WITH ALCOHOL ON 
DRIVING, Am J Addict. 2009; 18(3): 185–193.)
 Alcohol users tend to underestimate their degree of 
impairment
 Cannabis users tend to overestimate their degree of 
impairment
 Driving and simulator studies show marijuana use by drivers 
is likely to result in decreased speed and fewer attempts to 
overtake, as well as increased “following distance”
 Cannabis impairs automatic functions in driving but 
not conscious control
 Alcohol impairs conscious control but not so much 
automatic functions
 The synergistic impairment of automatic and conscious 
functions is why even low doses of alcohol with 
cannabis can lead to severe impairment
 Multiple studies from around the world (US, Australia, Switzerland, 
Sweden, etc…) seem to consistently find minimal danger with THC 
blood level below 5ng/mL with sudden spike in danger above 5 ng/mL
 In the US, 6 states with “per se” laws, typically with limit of 5 ng/mL 
(Nevada and Ohio limit of 2 ng/mL)
 12 states with “zero tolerance” laws
 All other states (including CA) use DUI standards, field sobriety tests, 
and “Drug Recognition Experts)
 Criteria vary state by state, some convict with “any” impairment, other 






 Cesamet (Nabilone): synthetic based, capsules, FDA 
approved for chemo-related nausea
 Marinol (Dronabinol): FDA approved for AIDS related 
weight loss and chemo related nausea, also synthetic, 
not as potent as Nabilone
 Dry mouth
 Increased tremor in some Parkinson’s patients







 Epidiolex: FDA approved June 2018
 Approved to treat Lennox-Gastaut syndrome or Dravet syndrome 
based seizures
 2002-2014, pregnant women in US based on aggregate data, increased 
from 2.4% to 3.9%. (Brown QL, Sarvet AL, Shmulewitz D, Martins SS, Wall MM, Hasin DS. Trends in marijuana use 
among pregnant and nonpregnant reproductive-aged women, 2002-2014. JAMA. 2017;317(2):207-209.)
 JAMA study, self report with toxicology testing, pregnant women in 
Northern California
 Kaiser Permanente population 2009-2016
 Rates of use (defined as any use in the past 30 days) increased from 
4.2% to 7.1 % (Wolff, et al. Trends in Self-reported and Biochemically Tested Marijuana Use Among Pregnant Females in 
California From 2009-2016. JAMA. 2017;318(24):2490-2491.)
 Colorado Based study found 50% increased 
likelihood of low birth weight but not small for 
gestational age, preterm birth, or neonatal 
intensive care unit admission. 5.7% prevalence 
rate of use (J Pediatr. 2018 Jun;197:90-96. doi: 10.1016/j.jpeds.2018.02.005. Epub 2018 Mar 28.)
 Another study found Maternal marijuana use was not associated with 
a composite of small for gestational age, spontaneous preterm birth, 
or hypertensive disorders of pregnancy. However, it was associated 
with an increased risk of neonatal morbidity. aOR of 3.11 for any form 
of complication (pulmonary morbidity, necrotizing enterocolitis, 
seizures, retinopathy of prematurity, infection morbidity, anemia 
requiring blood transfusion, neonatal surgery, hyperbilirubinemia, 
neurological morbidity, or death prior to hospital discharge) (Am J Obstet 
Gynecol. 2017 Oct;217(4):478.e1-478.e8. doi: 10.1016/j.ajog.2017.05.050.)
 Breastfeeding? 2.5% transmission rate (Obstet Gynecol. 2018 May;131(5):783-788. 
doi: 10.1097/AOG.0000000000002575.)
 In another study, median concentration of ∆9-THC was 9.47 
ng/mL (Bertrand et al. Marijuana Use by Breastfeeding Mothers and Cannabinoid Concentrations in Breast Milk 
Pediatrics. September 2018, VOLUME 142 / ISSUE 3)
 Long-term neurobehavioral effect of exposure to delta-
9-tetrahydrocannabinol on the developing brain is 
unclear. (some anatomical findings such as increased cortical thickness but 
unclear if any clinical significance)
